DexCom
DXCM
999 hedge funds and large institutions have $42.4B invested in DexCom in 2024 Q2 according to their latest regulatory filings, with 111 funds opening new positions, 445 increasing their positions, 307 reducing their positions, and 132 closing their positions.
45% more repeat investments, than reductions
Existing positions increased: 445 | Existing positions reduced: 307
2% less call options, than puts
Call options by funds: $518M | Put options by funds: $526M
1.52% less ownership
Funds ownership: 95.65% → 94.13% (-1.5%)
3% less funds holding
Funds holding: 1,032 → 999 (-33)
16% less first-time investments, than exits
New positions opened: 111 | Existing positions closed: 132
17% less capital invested
Capital invested by funds: $51.1B → $42.4B (-$8.67B)
40% less funds holding in top 10
Funds holding in top 10: 25 → 15 (-10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$244M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$241M |
| 3 |
Goldman Sachs
New York
|
+$160M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$143M |
| 5 |
JP Morgan Chase
New York
|
+$128M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$253M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
-$191M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$188M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$103M |
| 5 |
Jane Street
New York
|
-$95.5M |
DXCM Hedge Fund Activity: Q2 2024 in Review
999 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q2 2024, worth a combined $42.4B — down 17% from $51.1B a quarter earlier.
Sellers outnumbered buyers: 132 funds closed out of DXCM and 111 opened new positions — a net loss of 21 holders — while 307 trimmed existing stakes and 445 added.
The largest buyer was UBS AM, adding an estimated $244M. The largest seller was 1832 Asset Management, exiting entirely with an estimated $253M sold.
- 999 institutional investors held DexCom (DXCM) as of Q2 2024, down from 1,032 in Q1 2024.
- Funds reported $42.4B of DexCom stock for Q2 2024, down 17% quarter-over-quarter.
- 111 funds opened new DexCom positions in Q2 2024 and 132 closed out, a net change of -21 holders.
- The largest DexCom buyer in Q2 2024 was UBS AM, an estimated $244M added.
- The largest DexCom seller in Q2 2024 was 1832 Asset Management, an estimated $253M sold.
Based on aggregated 13F filings for Q2 2024.